Metropolitan Life Insurance Company (MetLife)’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,056
Closed -$63.5K 676
2024
Q1
$63.5K Hold
9,056
﹤0.01% 1279
2023
Q4
$99.2K Hold
9,056
﹤0.01% 1084
2023
Q3
$99.4K Buy
9,056
+459
+5% +$6.56K 0.01% 1015
2023
Q2
$136K Buy
8,597
+1,740
+25% +$20.2K 0.01% 873
2023
Q1
$89.5K Sell
6,857
-856
-11% -$7.03K ﹤0.01% 1048
2022
Q4
$84K Hold
7,713
﹤0.01% 1153
2022
Q3
$124K Hold
7,713
0.01% 896
2022
Q2
$60.1K Buy
+7,713
New +$72.5K ﹤0.01% 1384

Other funds holding ENVX

Metropolitan Life Insurance Company (MetLife)'s ENVX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Enovix (ENVX) in Q2 2024, closing a stake of 9,056 shares — an estimated $63.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ENVX in Q2 2022 and held it in 8 quarters. The position peaked at $136K in Q2 2023. 277 funds tracked by Wall St. Rank hold ENVX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Enovix position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 9,056 Enovix shares in Q2 2024, an estimated $63.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Enovix in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Enovix position peaked at $136K in Q2 2023.
  • 277 funds tracked by Wall St. Rank held Enovix as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.